Decenes Group

Information sheet

These substances were identified for action under the Chemicals Management Plan (CMP).

Summary of publications
Substance group	CAS RN	Common name (acronym)	DSL name	Draft screening assessment	Risk management scope	Proposed conclusion on section 64 criteria	Follow-up activities
Decenes Group	68649-11-6^{Table 1 Footnote a}	Hydrogenated didecene	1-Decene, dimer, hydrogenated	HTML	HTML	Meets one or more of the criteria	Refer to risk management scope
Decenes Group	68649-12-7^{Table 1 Footnote a}	Hydrogenated trimer and tetramer of decene (HTTD)	1-Decene, tetramer, mixed with 1-decene trimer, hydrogenated	HTML	HTML	Meets one or more of the criteria	Refer to risk management scope
Table 1 Footnote a This CAS RN is a UVCB (unknown or variable composition, complex reaction products, or biological materials). Table 1 Return to footnote a referrer

Timelines
Date	Activity
January 2022	Anticipated publication of the final screening assessment and proposed risk management approach.
January 9, 2021	Publication and start of 60-day public comment period on the draft screening assessment and risk management scope. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 2.

Report a problem or mistake on this page

Please select all that apply:

A link, button or video is not working

It has a spelling mistake

Information is missing

Information is outdated or wrong

I can't find what I'm looking for

Other issue not in this list